Corentec Co

Corentec Co Debt Growth

The Year-over-Year Debt Growth of Corentec Co (104540.KQ) as of Oct 29, 2026 is -82.93 %. In the previous year, Year-over-Year Debt Growth was 53.95 % — a change of -253.71% (lower).

Debt Growth

-82.93 %

YoY

-253.71%

Last updated:

Year-over-Year Debt Growth of Corentec Co is 2025 -82.93 % . Year-over-Year Debt Growth of Corentec Co was 2024 53.95 % . It decreases by -253.71% lower compared to the previous year.

The Corentec Co Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2018
3.38 KRW
Jan 1, 2019
-50.21 KRW
Jan 1, 2020
170.90 KRW
Jan 1, 2021
22.89 KRW
Jan 1, 2022
-19.98 KRW
Jan 1, 2023
-47.18 KRW
Jan 1, 2024
53.95 KRW
Jan 1, 2025
-82.93 KRW
The Corentec Co Debt Growth history
YEARDebt GrowthYoY
-82.93 %-253.71%
53.95 %-214.34%
-47.18 %+136.15%
-19.98 %-187.30%
22.89 %-86.61%
170.90 %-440.37%
-50.21 %-1,583.77%
3.38 %-89.61%
32.58 %-83.91%
202.51 %-455.82%
-56.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Year-over-Year Debt Growth of Corentec Co is -82.93 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Corentec Co

All Key Metrics — Corentec Co